The FDA will likely make a decision about approving Pfizer’s vaccine “shortly after” an advisory committee meeting on Thursday. The agency has found “no specific safety concerns” about the vaccine.
(Image credit: Al Drago/AFP via Getty Images)
The FDA will likely make a decision about approving Pfizer’s vaccine “shortly after” an advisory committee meeting on Thursday. The agency has found “no specific safety concerns” about the vaccine.
(Image credit: Al Drago/AFP via Getty Images)